|
|
|
|
AANMA Clarifies FDA Asthma Medication Warnings
Allergy & Asthma Network Mothers of Asthmatics (AANMA) recently offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair (fluticasone and salmeterol), Foradil (formoterol), Serevent (salmeterol) and...
|
|
|
Leading Patient Education Group Provides Straight Answers To FDA's Announcement About Asthma Medications
Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair (fluticasone and salmeterol), Foradil (formoterol), Severent (salmeterol) and Symbicort ...
|
|
|
FDA's warning over LABA medications for asthma: AANMA offers guidance
Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair (fluticasone and salmeterol), Foradil (formoterol), Severent (salmeterol) and Symbicort...
|
|
|
Leading Patient Education Group Provides Straight Answers to FDA's Announcement about Asthma Medications
Source: Allergy & Asthma Network Mothers of Asthmatics (AANMA) Newswise Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ...
|
|
|
Leading Patient Education Group Provides Straight Answers to FDA's Announcement about Asthma Medications
Newswise - Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair (fluticasone and salmeterol), Foradil (formoterol), Severent (salmeterol)...
|
|
|
Sepracor CEO resigns, takes job in N.C
Marlborough drug company Sepracor Inc.said yesterday that Adrian Adams, its president and chief executive, had resigned. Last year, the company entered into an agreement to be purchased by Dainippon Sumitomo Pharma Co. of Japan for $2.6 billion, and...
|
|
|
Doctors Need More Freedom Of Choice In Rescue Asthma Therapy
A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.100% of the doctors surveyed...
|
|
|
Survey reveals need for better access to levalbuterol for asthma patients
A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.100% of the doctors surveyed...
|
|
|
Doctors Need More Freedom of Choice in Rescue Asthma Therapy
Source: LifeSciences Press (LSP) Newswise A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected...
|
|
|
The heart of the deal: A look at notable 09 M&As: M&A activity showed some signs of promise toward the tail end of last year, but the pace was still well below historical norms. That said, 2009 produced a few notable deals. The BBJs Jackie Noblett
EMC Corp.and Data Domain Inc. Deal value: $2.1 billion. Announced: July 8. It's a deal: The Hopkinton data storage giant had to fight hard and pay big to win Data Domain from its Silicon Valley neighbor, NetApp Inc. But Data Domains core technology...
|
